We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+0.97%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.23B
AUM Growth
-$1.26B
(-15%)
Cap. Flow
-$1.29B
Cap. Flow
% of AUM
-17.85%
Top 10 Holdings %
Top 10 Hldgs %
17.57%
Holding
1,950
New
32
Increased
184
Reduced
1,428
Closed
301
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$4.63M |
| 2 |
Consolidated Edison
ED
|
+$2.41M |
| 3 |
ProShares Global Listed Private Equity ETF
PEX
|
+$2.33M |
| 4 |
Sysco
SYY
|
+$2.07M |
| 5 |
Pentair
PNR
|
+$1.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$94.7M |
| 2 |
Microsoft
MSFT
|
+$47.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$38.2M |
| 4 |
Gilead Sciences
GILD
|
+$21.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$20.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.1% |
| 2 | Technology | 15.48% |
| 3 | Financials | 15.36% |
| 4 | Consumer Discretionary | 7.61% |
| 5 | Communication Services | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Visa
V
$682B
| $44.1M | 0.61% |
656,579
-107,942
| -14% | -$7.32M |
|
27
Qualcomm
QCOM
$181B
| $42.7M | 0.59% |
682,272
-200,077
| -23% | -$13.6M |
|
|
ALXN
28
DELISTED
Alexion Pharmaceuticals
ALXN
| $42.5M | 0.59% |
235,377
-4,385
| -2% | -$757K |
|
29
IBM
IBM
$200B
| $42M | 0.58% |
270,390
-63,826
| -19% | -$10.3M |
|
30
Pfizer
PFE
$143B
| $40.9M | 0.57% |
1,284,416
-218,732
| -15% | -$7.13M |
|
31
AT&T
T
$152B
| $38.7M | 0.54% |
1,442,085
-158,303
| -10% | -$4.09M |
|
32
Coca-Cola
KO
$351B
| $38.1M | 0.53% |
970,296
-95,220
| -9% | -$3.87M |
|
33
GE Aerospace
GE
$364B
| $37.9M | 0.52% |
297,404
-78,367
| -21% | -$10.2M |
|
34
McDonald's
MCD
$190B
| $37.4M | 0.52% |
392,972
-51,404
| -12% | -$4.97M |
|
35
Walmart Inc
WMT
$909B
| $36.4M | 0.5% |
1,539,549
-114,690
| -7% | -$2.92M |
|
36
Walt Disney
DIS
$170B
| $36.2M | 0.5% |
316,896
-78,243
| -20% | -$8.59M |
|
37
AbbVie
ABBV
$450B
| $35.6M | 0.49% |
529,809
-4,437
| -0.8% | -$290K |
|
38
Merck
MRK
$315B
| $35M | 0.48% |
644,329
-119,830
| -16% | -$6.72M |
|
39
UnitedHealth
UNH
$387B
| $34.8M | 0.48% |
284,900
-56,094
| -16% | -$6.64M |
|
40
Vertex Pharmaceuticals
VRTX
$123B
| $34.3M | 0.47% |
277,411
-31,982
| -10% | -$4.03M |
|
41
Viatris
VTRS
$20.1B
| $34.1M | 0.47% |
503,218
-5,504
| -1% | -$389K |
|
42
PepsiCo
PEP
$187B
| $33.9M | 0.47% |
363,309
-28,943
| -7% | -$2.77M |
|
43
Illumina
ILMN
$28.2B
| $33.7M | 0.47% |
158,566
-13,395
| -8% | -$2.62M |
|
44
Medtronic
MDT
$106B
| $31.7M | 0.44% |
427,222
-20,667
| -5% | -$1.58M |
|
45
Home Depot
HD
$338B
| $31.6M | 0.44% |
284,067
-71,958
| -20% | -$8.06M |
|
46
Starbucks
SBUX
$120B
| $31.2M | 0.43% |
582,097
-163,903
| -22% | -$8.32M |
|
|
ESRX
47
DELISTED
Express Scripts Holding Company
ESRX
| $30.9M | 0.43% |
347,396
-84,114
| -19% | -$7.35M |
|
48
Verizon
VZ
$182B
| $29.5M | 0.41% |
633,002
-152,058
| -19% | -$7.44M |
|
49
eBay
EBAY
$49.8B
| $28.9M | 0.4% |
1,137,897
-317,481
| -22% | -$7.92M |
|
50
Automatic Data Processing
ADP
$102B
| $28.6M | 0.4% |
356,304
-33,239
| -9% | -$2.83M |
|
Similar funds
ProShare Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, ProShare Advisors held 1,950 positions worth $7.23B, down 15% from $8.49B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
ProShare Advisors withdrew a net $1.29B in Q2 2015, closing 301 positions and reducing 1,428 holdings. Its most notable exit was PHARMACYCLICS INC, an estimated $16.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
Against the trend, ProShare Advisors opened a new position in Uniti Group worth $1.66M.
- ProShare Advisors's largest Q2 2015 buy was Uniti Group: 67,007 shares worth $1.66M.
- ProShare Advisors added most to Equinix in Q2 2015, an estimated $4.63M increase.
- ProShare Advisors's biggest Q2 2015 reduction was Apple, cutting an estimated $94.7M.
- ProShare Advisors fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $16.5M.
- ProShare Advisors's ten largest holdings make up 18% of its $7.23B portfolio in Q2 2015.
- ProShare Advisors opened 32 new positions and closed 301 in Q2 2015.
- ProShare Advisors's portfolio value fell 15% quarter-over-quarter to $7.23B.
Based on ProShare Advisors's 13F filing for Q2 2015, filed 11 Aug 2015.